Immunomedics, Inc. (IMMU) has seen some recent activity in the marketplace and its shares were last quoted at $43.18 yesterday. Investors are starting to take notice of IMMU as the shares traded as high as $44.39 and as low as $42.02 in the prior market trading day.

Immunomedics, Inc. (IMMU) average trading volume is 3.14M. However, in the prior market trading day Immunomedics, Inc. (IMMU) exchanged 1,822,802 shares. The 1st downside support level on IMMU is $42.88 and the 1st upside resistance level on IMMU is $46.38. IMMU 50 day moving average is $40.21 and IMMU two hundred day moving average is $26.89.

Immunomedics, Inc. (IMMU) recent performance has been shown by the recent movement in IMMU shares. IMMU has performed 3.92% over the past 4 weeks, IMMU has performed 33.68% over the past 90 days and IMMU has shown 191.76% over the past 12 months. Immunomedics, Inc. (IMMU) has a 1 year range of $8.80 to $44.91. Immunomedics, Inc. (IMMU) is trading 390.68% from its 1 year low and -3.85% from its 1 year high. Immunomedics, Inc. (IMMU) is showing a 13.13% short float showing the quantity short in the float.

IMMU has 213.25M shares outstanding and 204.55M shares in the float. Immunomedics, Inc. (IMMU) presently has a market cap of $10.23B and income of -362.90M. The EPS next quarter for IMMU is -0.35 and forecasted EPS next year is 40.10%. The market cap of Immunomedics, Inc. (IMMU) at $10.23B signifies how many Investors own shares of IMMU and is calculated off the last price ($43.18) of IMMU and the quantity of shares outstanding (213.25M) with Immunomedics, Inc. (IMMU).

Immunomedics, Inc. (IMMU) has aggregate cash (mrq) of 975.52M, aggregate cash per share (mrq) of 4.22, aggregate debt of IMMU rests at 10.14M and aggregate debt/equity (mrq) is 1.71. . Immunomedics, Inc. (IMMU) operational cash flow (ttm) is -257.96M, IMMU leveraged free cash flow (ttm) is -227.02M.

IMMU is trading 1.77% above (bullish) its SMA20, 14.79% above (bullish) its SMA50 and 77.71% above (bullish) its SMA200.